← Evidence map

ArticleACS pharmacology & translational science2023

Deuremidevir and Simnotrelvir-Ritonavir for the Treatment of COVID-19.

Ke-Wei ZhuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37705591